Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to.